Director/PDMR Shareholding

RNS Number : 6587A

GlaxoSmithKline PLC

02 April 2012

 



 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.

On 30 March 2012, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £14.07 per Ordinary Share, and notional ADSs at a price of $45.10 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 January 2012 to 31 March 2012:

Non Executive Director	Ordinary Shares	American Depositary Shares (ADSs)
Sir Christopher Gent	2,398.721
Professor Sir Roy Anderson	466.418
Dr Stephanie Burns		588.118
Stacey Cartwright	333.156
Lawrence Culp		914.850
Sir Crispin Davis	1,687.989
Judy Lewent		294.059
Sir Deryck Maughan		1,176.236
James Murdoch	1,332.623
Dr Daniel Podolsky		1,078.216
Tom de Swaan	688.522
Sir Robert Wilson	466.418

The Company and the Non-Executive Directors were informed of these allocations on 2 April 2012.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

2 April 2012

 

END

 

 

RDSQLLFBLZFFBBX